Chronic non-atrophic gastritis
Conditions
Interventions
Stomach heat syndrome:Zuojin pill
Stomach cold syndrome:Wuzhuyu decoction
Sponsors
Fifth Medical Center of PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ? Age 18 to 65 years old, male or female; ? Western medicine diagnosed as chronic non-atrophic gastritis; ? TCM syndrome differentiation is the liver-fire invading stomach syndrome or liver-stomach deficiency-cold syndrome; ? Subjects of childbearing age who voluntarily take effective contraceptive measures during the trial; ? Voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: ? Gastroscopy with esophageal disease, peptic ulcer, tumor, bleeding lesions; ? Combined with severe dysplasia of gastric mucosa and pathological diagnosis of suspected malignant transformation; ? Patients with autoimmune gastritis were excluded by serum gastrin, vitamin B12 levels and related autoantibodies (anti-parietal cell antibodies and anti-intrinsic factor antibodies); ? Have serious primary heart, liver, lung, kidney, blood or serious diseases that affect their survival, such as tumors, AIDS or coagulation disorders; ? Laboratory examination: Scr>N (N is the upper limit of normal value); ALT, AST>N; white blood cells <3.0×109/L; ? Allergic constitution, such as those who are allergic to drugs or food; or those who are known to be allergic to research drugs; ? Patients with alcoholism and drug dependence, with a history of epilepsy or with mental disorders; ? Pregnant, lactating women or those planning to become pregnant; ? Those who have participated in or are participating in other clinical trials within 3 months; ? Other patients deemed unsuitable for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical observational indicators;Liver damage indicators;Kidney damage indicators;Nerve damage evaluation index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Histopathological findings;TCM syndrome score;Endogenous metabolites;Clinical efficacy indicators;Gastroscopy results; | — |
Countries
China
Contacts
Public ContactYanling Zhao
Chinese People's Liberation Army General Hospital
Outcome results
None listed